Theravance Biopharma, Inc. (TBPH)
Pharmaceutical Preparations · Healthcare · $860M
Intrinsic Value (Consensus)
$25.85
Current Price
$16.69
Margin of Safety
+54.9%
54.9% Below Intrinsic Value
Value: $26
Price: $17
Valuation Model Estimates
Current Price: $16.69
DCF (Discounted Cash Flow)
$215.20
Graham Number
$16.34
Earnings Power Value
$20.00
Relative Value (P/E)
$41.20
Dividend Discount Model
Not applicable
—
Consensus Value
$25.85
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
86
Profitability
25/25
Strength
17/25
Valuation
22/25
Growth
22/25
Financial Health Signals
Strong profitability — ROE of 36% (above 20% is excellent)
Strong earnings growth (20% YoY)
High free cash flow yield (27.5%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $2.06
- EPS (Forward)
- $2.47
- Book Value
- $5.76
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 35.7%
- Debt/Equity
- —
- Revenue Growth
- 437.6%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance